The Sydney Diabetes Prevention Program: A community-based translational study

详细信息    查看全文

• 作者：Stephen Colagiuri (1)
  Philip Vita (2)
  Magnolia Cardona-Morrell (2)
  Maria Fiatarone Singh (3)
  Louise Farrell (2)
  Andrew Milat (4)
  Marion Haas (5)
  Adrian Bauman (6)
  
• 刊名：BMC Public Health
• 出版年：2010
• 出版时间：December 2010
• 年：2010
• 卷：10
• 期：1
• 全文大小：666KB
• 参考文献：1. Shaw J, Sicree R, Zimmet P: Global estimates of the prevalence of diabetes for 2010 and 2030. / Diab Res Clin Pract 2010, 87:4鈥?4. CrossRef
  2. Dunstan DW, Zimmet PZ, Welborn TA, de Courten MP, Cameron AJ, Sicree RA, Dwyer T, Colagiuri S, Jolley D, Knuiman M, Atkins R, Shaw JE: The Rising Prevalence of Diabetes and Impaired Glucose Tolerance: The Australian Diabetes, Obesity and Lifestyle Study. / Diabetes Care 2002, 25:829鈥?34. CrossRef
  3. Magliano DJ, Barr ELM, Zimmet PZ, Cameron AJ, Dunstan DW, Colagiuri S, Jolley D, Owen N, Phillips P, Tapp RJ, Welborn TA, Shaw JE: Glucose indices, health behaviours and incidence of diabetes in Australia: the AusDiab study. / Diabetes Care 2008, 31:267鈥?2. CrossRef
  4. Colagiuri S, Colagiuri R, Conway B, Davey P, Grainger D: Assessing the burden of diabetes in Australia. In / DiabCost Australia. Diabetes Australia, Canberra; 2004.
  5. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Aunola S, Cepaitis Z, Moltchanov V, Hakumaki M, Mannelin M, Martikkala V, Sundvall J, Uusitupa M, The Finnish Diabetes Prevention Study Group: Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance. / N Engl J Med 2001, 344:1343鈥?350. CrossRef
  6. Knowler WC, Barrett-Connor E, Fowler SF, Hamman RF, Lachin IM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. / N Engl J Med 2002, 346:393鈥?03. CrossRef
  7. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. / Diabetes Care 1997, 20:537鈥?44. CrossRef
  8. Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K, Hamalainen H, Harkonen P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle TT, Uusitupa M, Tuomilehto J, Finnish Diabetes Prevention Study G: Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. / Lancet 2006, 368:1673鈥?679. CrossRef
  9. Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, Li H, Li H, Jiang Y, An Y, Shuai Y, Zhang B, Zhang J, Thompson TJ, Gerzoff RB, Roglic G, Hu Y, Bennett PH: The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. / Lancet 2008, 371:1783鈥?789. CrossRef
  10. Kosaka K, Noda M, Kuzuya T: Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. / Diab Res Clin Pract 2005, 67:152鈥?62. CrossRef
  11. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar A, Vijay V: The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). / Diabetologia 2006, 49:289鈥?97. CrossRef
  12. Kilkkinen A, Heistaro S, Laatikainen T, Janus E, Chapman A, Absetz P, Dunbar J: Prevention of type 2 diabetes in a primary health care setting: Interim results from the Greater Green Triangle (GGT) Diabetes Prevention Project. / Diab Res Clin Pract 2007, 76:460鈥?62. CrossRef
  13. Absetz P, Valve R, Oldenburg B, Heinonen H, Nissinen A, Fogelholm M, Ilvesm盲ki V, Talja M, Uutela A: Type 2 Diabetes Prevention in the "Real World". / Diabetes Care 2007, 30:2465鈥?470. CrossRef
  14. Glasgow R, Green LW, Klesges LM, Abrams DB, Fisher EB, Goldstein MG, Hayman LL, Ockene JK, Orleans CT: External Validity: We Need to do More. / Annals of Behavioural Medicine 2006, 31:105鈥?08. CrossRef
  15. Catford J: Advancing the 'science of delivery' of health promotion: not just the 'science of discovery. / Health Promotion International 2009, 24:1鈥?. CrossRef
  16. Chen L, Magliano DJ, Balkau B, Colagiuri S, Zimmet PZ, Tonkin AM, Mitchell P, Phillips PJ, Shaw JE: AUSDRISK: an Australian type 2 diabetes risk assessment tool based on demographic, lifestyle and simple anthropometric measures. / Med J Aust 2010, 192:197鈥?02.
  17. Willey KA, Singh MA: Battling insulin resistance in elderly obese people with type 2 diabetes: bring on the heavy weights. / Diabetes Care 2003, 26:1580鈥?. CrossRef
  18. Sigal R, Kenney G, Wasserman D, Castaneda-Sceppa C: Physical activity/exercise and type 2 diabetes. / Diabetes Care 2004, 27:2518鈥?9. CrossRef
  19. Boule NG, Haddad E, Kenny GP, Wells GA, Sigal RJ: Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. / Jama 2001, 286:1218鈥?7. CrossRef
  20. Pedersen BK, Saltin B: Evidence for prescribing exercise as therapy in chronic disease. / Scand J Med Sci Sports 2006,16(Suppl 1):3鈥?3. CrossRef
  21. Daly RM, Dunstan DW, Owen N, Jolley D, Shaw JE, Zimmet PZ: Does high-intensity resistance training maintain bone mass during moderate weight loss in older overweight adults with type 2 diabetes? / Osteoporos Int 2005, 16:1703鈥?2. CrossRef
  22. Prochaska JO, DiClimente CC: / The transtheoretical approach: Crossing traditional boundaries of therapy. Homewood, IL: Dow Jones/Irwin; 1984.
  23. Bandura A: Self-efficacy mechanisms in human agency. / American Psychologist 1982, 37:122鈥?47. CrossRef
  24. Miller WR, Rollnick S: / Motivational interviewing: preparing people to change addictive behaviour. New York: Guilford Press; 1991.
  25. The International Society for the Advancement of Kinanthropometry [http://www.isakonline.com/]
  26. Washburn RA, Smith KW, Jette AM, Janney CA: The Physical Activity Scale for the Elderly (PASE): development and evaluation. / J Clin Epidemiol 1993, 46:153鈥?2. CrossRef
  27. The Nutrition Company. About FoodWorks [http://www.nutritionco.com/FoodWorks.htm]
  28. Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE, Diabetes Prevention Program Research Group: The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 diabetes in adults with impaired glucose tolerance. / Annals of Internal Medicine 2005, 142:323鈥?32.
  29. Palmer AJ, Roze S, Valentine WJ, Spinas GA, Shaw JE, Zimmet PZ: Intensive Lifestyle Changes or Metformin in Patients with Impaired Glucose Tolerance: Modeling the Long-Term Health Economic Implications of the Diabetes Prevention Program in Australia, France, Germany, Switzerland, and the United Kingdom. / Clinical Therapeutics 2004, 26:304鈥?21. CrossRef
  30. Eddy DM, Schlessinger L, Kahn R: Clinical Outcomes and Cost-Effectiveness of Strategies for Managing People at High Risk for Diabetes. / Annals of Internal Medicine 2005, 143:251鈥?64.
  31. Jacobs-Van der Bruggen MAM, Bos G, Bemelmans WJ, Hoogenveen RT, Vijgen SM, Baan CA: Lifestyle Interventions Are Cost-Effective in People With Different Levels of Diabetes Risk. / Diabetes Care 2007, 30:128鈥?34. CrossRef
  32. Colagiuri S, Walker A: An economic model of diabetes to evaluate prevention and care strategies in Australia. / Health Affairs 2008, 27:256鈥?68. CrossRef
  33. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/10/328/prepub
  
• 作者单位：Stephen Colagiuri (1)
  Philip Vita (2)
  Magnolia Cardona-Morrell (2)
  Maria Fiatarone Singh (3)
  Louise Farrell (2)
  Andrew Milat (4)
  Marion Haas (5)
  Adrian Bauman (6)
  
  1. Boden Institute of Obesity, Nutrition and Exercise, University of Sydney, NSW, Australia
  2. Sydney South West Area Health Service, NSW, Australia
  3. Exercise, Health and Performance Faculty Research Group, Faculty of Health Sciences, and Sydney Medical School, University of Sydney, NSW, Australia
  4. NSW Department of Health, NSW, Australia
  5. University of Technology, NSW, Australia
  6. School of Public Health, University of Sydney, NSW, Australia
  
• ISSN：1471-2458

文摘

Background Type 2 diabetes is a major public health problem in Australia with prevalence increasing in parallel with increasing obesity. Prevention is an essential component of strategies to reduce the diabetes burden. There is strong and consistent evidence from randomised controlled trials that type 2 diabetes can be prevented or delayed through lifestyle modification which improves diet, increases physical activity and achieves weight loss in at risk people. The current challenge is to translate this evidence into routine community settings, determine feasible and effective ways of delivering the intervention and providing on-going support to sustain successful behavioural changes. Methods/Design The Sydney Diabetes Prevention Program (SDPP) is a translational study which will be conducted in 1,550 participants aged 50-65 years (including 100 indigenous people aged 18 years and older) at high risk of future development of diabetes. Participants will be identified through a screening and recruitment program delivered through primary care and will be offered a community-based lifestyle modification intervention. The intervention comprises an initial individual session and three group sessions based on behaviour change principles and focuses on five goals: 5% weight loss, 210 min/week physical activity (aerobic and strength training exercise), limit dietary fat and saturated fat to less than 30% and 10% of energy intake respectively, and at least 15 g/1000 kcal dietary fibre. This is followed by 3-monthly contact with participants to review progress and offer ongoing lifestyle advice for 12 months. The effectiveness and costs of the program on diabetes-related risk factors will be evaluated. Main outcomes include changes in weight, physical activity, and dietary changes (fat, saturated fat and fibre intake). Secondary outcomes include changes in waist circumference, fasting plasma glucose, blood pressure, lipids, quality of life, psychological well being, medication use and health service utilization. Discussion This translational study will ascertain the reach, feasibility, effectiveness and cost-effectiveness of a lifestyle modification program delivered in a community setting through primary health care. If demonstrated to be effective, it will result in recommendations for policy change and practical methods for a wider community program for preventing or delaying the onset of type 2 diabetes in high risk people.